The Latest Cardiac and Vascular News
New study shows hypertensive adults can face six times higher heart attack risk after a bout with the seasonal flu LAKE FOREST, Ill., Nov. 23, 2021 /PRNewswire/ — As cold and flu season intensifies across the U.S., global heart health leader OMRON Healthcare, Inc., is issuing a national health alert to the increased […]
MEMPHIS, Tenn., Nov. 22, 2021 /PRNewswire/ — Tony and Karyn Tanner of Bossier City, La., knew that this day was coming sooner rather than later for their 17-year-old daughter Madi. Born with tetralogy of Fallot (TOF), a congenital heart defect that changes the flow of blood through the heart, she needed a pulmonary valve replacement, […]
ST. LOUIS PARK, Minn., Nov. 22, 2021 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, announced positive 30-day results following the first successful worldwide procedure using multiple chords to a single anchor. The […]
Approved protocol amendment enables enrollment of ATTR-CM patients in the ongoing first-in-human study of NTLA-2001, a systemically delivered CRISPR/Cas9-based therapy CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA) announced today that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has approved a protocol amendment […]
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review of the New Drug Application (NDA) for mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to April 28, 2022. The FDA notified Bristol Myers Squibb on […]
LONGMONT, Colo., Nov. 18, 2021 /PRNewswire/ — Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., today announced a partnership with Acarix, a Swedish medical device company that provides innovative solutions for rapid AI-based rule out of […]
Novocardia Joins List of Fast-Growing Private Companies Transforming Health Care Delivery & Outcomes NEW YORK, Nov. 18, 2021 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care delivery platform, today announced it has been named a “Rising Disruptor” by Bernstein, a global equity research firm, in its 2021 report on the most disruptive private […]
More donor hearts safely traveling long distances with the Paragonix SherpaPak® Cardiac Transport System CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. is announcing a major milestone of 1,000 preserved donor heart transports since it began clinical use in 2018, with its flagship product, the Paragonix SherpaPak® Cardiac Transport System (CTS). The Paragonix SherpaPak CTS is the […]
VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce total ischemic events by 32% in patients with prior PAD DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today reported an overview of new data relating to VASCEPA®/VAZKEPA (icosapent ethyl) presented at the […]
Two New Studies Presented at the American Heart Association Scientific Sessions 2021, Adoption of Technology Reported as “Excellent” and “Valuable” by Lead Authors Oak Ridge, TN, Nov. 16, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the […]
